Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013–2024)
Abstract Background Patient-reported outcomes (PROs) in systemic rheumatic diseases (SRDs) are in the forefront of clinical research. However, a comprehensive evaluation of PROs in pivotal trials supporting SRD drug approval is lacking. Objective This study aims to systematically characterize the us...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Health and Quality of Life Outcomes |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12955-025-02386-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|